New York State Common Retirement Fund Candel Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,700 shares of CADL stock, worth $15,078. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,700
Previous 17,000
90.0%
Holding current value
$15,078
Previous $105,000
88.57%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CADL
# of Institutions
56Shares Held
6.41MCall Options Held
109KPut Options Held
130K-
Northpond Ventures, LLC1.94MShares$17.2 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA946KShares$8.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$7.3 Million0.0% of portfolio
-
State Street Corp Boston, MA492KShares$4.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$3.98 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $256M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...